Tridentify Partners with ADYTON to Expand the QTA Tracer System® and its unique Shelf-Life function (based on stability data) Across Central Europe
- Ann-Christine Jungmar
- May 28
- 1 min read
Tridentify is proud to announce a new distribution agreement with ADYTON, a leading commercialization partner for advanced healthcare technologies in Central Europe.
Through this partnership, the QTA Tracer System® and its Shelf-Life Management feature, will be introduced further into the transfusion medicine market across Poland, Czechia, and Slovakia, strengthen Tridentify’s presence in the region and expand access to safer and more efficient blood product management solutions. Tridentify is the only European known Medtech Company with a MDD class IIa device with shelf-life management. MDR in 2026.
Please read the pressrelease attached.
Comments